Equity Transactions (Details Narrative) - USD ($)			1 Months Ended			12 Months Ended
	Feb. 08, 2021	Feb. 02, 2021	Jun. 30, 2023	Sep. 01, 2021	Jun. 28, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Common stock for prepayment of interest on note payable, value						$ 607,020
Common stock for prepayment of interest on note payable, share						134,000
Common stock shares issued during period, value			$ 162,727
Common stock shares issued during period, shares			90,909
Common stock issued during period for acquisition value						$ 6,000,000	$ 0
Common stock issued during period for acquisition						607,004	0
Common Stock, shares authorized			100,000,000			100,000,000	100,000,000
Preferred stock, shares authorized			100,000,000			100,000,000	100,000,000
Preferred stock, par value			$ 0.001			$ 0.001	$ 0.001
Preferred stock, shares issued			500,000			500,000	500,000
Common Stock, shares issued			20,215,961			20,215,961	16,713,345
VitaMedica [Member]
Common stock issued during period for acquisition value						$ 41,363	$ 482,000
Common stock issued during period for acquisition							100,000
Infusionz [Member]
Common stock issued during period for acquisition value						$ 6,000,000	$ 1,764,876
Common stock issued during period for acquisition						1,247,403	306,945
E-Core Technologies Inc [Member]
Common stock issued during period for acquisition value						$ 6,000,000
Common stock issued during period for acquisition						1,247,403
Common Stock Shares [Member]
Common stock issued during period for acquisition value				$ 83,334
Common stock issued during period for acquisition				127,500
Proceeds from issuance of preferred stock					$ 12,650,000
Net proceeds after deducting the underwriting commissions, discounts, and offering expenses payable					$ 10,950,315
Common stock percentage offered to the public	15.00%
Sale of common stock to underwriters upon the full exercise of the option					330,000
Acquisition liability				$ 1,764,876
SharesIssued				306,935
Common Stock, shares authorized	20,000,000
Common stock per share	$ 4.50
Common Stock, shares issued					2,530,000
Common Stocks [Member] | Infusionz [Member]
Common stock issued during period for acquisition value								$ 526,404
Common stock issued during period for acquisition								1,235,124
Convertible Preferred Stock [Member]
Preferred stock, shares authorized			1,000,000			1,000,000
Preferred stock, par value			$ 0.001			$ 0.001
Preferred stock, shares issued			500,000			500,000
Preferred stock convertible into shares of common stock ratio		preferred stock is convertible into the Company’s common stock at a ratio of 1.8 shares of preferred stock for a single share				This preferred stock is convertible into shares of common stock at a ratio of 1.8 shares of preferred stock for a single share
Stock repurchase program						$ 500,000
Number of common stock shares converted									277,778
Conversion of shares of preferred stock									50,000
Preferred stock converted into shares of common stock			500,000			500,000
Proceeds from shares sold						$ 50,000